Concepedia

Publication | Closed Access

Kaempferol as a Potential PAK4 Inhibitor in Triple Negative Breast Cancer: Extra Precision Glide Docking and Free Energy Calculation

DOI

17

Citations

0

References

2019

Year

Michael Arowosegbe, Oluwamuyiwa T. Amusan, Segun Adeola, Oluwatosin B. Adu, Israel A. Akinola, Bimpe Folashade Ogungbe, Olaposi Idowu Omotuyi, Gbemisola Morounke Saibu, Adewale J. Ogunleye, Ramon I. Kanmodi,
Current Drug Discovery Technologies

Abstract

We, therefore, put forward a logical argument that kaempferol can be further evaluated as a potential PAK4 inhibitor in TNBC.